Ad is loading...
MENU
VIRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viracta Therapeutics (VIRX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

VIRX is expected to report earnings to fall 29.63% to -18 cents per share on March 18

Viracta Therapeutics VIRX Stock Earnings Reports
Q4'24
Est.
$-0.19
Q3'24
Est.
$-0.27
Q2'24
Beat
by $0.12
Q1'24
Beat
by $0.12
Q4'23
Missed
by $0.04
The last earnings report on November 13 showed earnings per share of -27 cents, meeting the estimate of -27 cents. With 1.15M shares outstanding, the current market capitalization sits at 5.95M.
View a ticker or compare two or three
VIRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of oncology therapeutics for treatment of solid and hematologic cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2533 South Coast Highway 101
Phone
+1 858 400-8470
Employees
40
Web
https://www.viracta.com